R3 Vascular is developing a world-class Bioresorbable scaffold technology with a sirolimus coating for the treatment of peripheral arterial disease.
Location: United States, California, Livermore
Employees: 1-10
Total raised: $87M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | 415 Capita... | 415capital... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 20.05.2024 | Series B | $87M | - |
Mentions in press and media 22
| Date | Title | Description |
| 21.05.2024 | R3 Vascular's Breakthrough in the Medical Device Landscape | R3 Vascular, a pioneering medical device company based in Mountain View, California, has recently captured the attention of the industry with its groundbreaking bioresorbable scaffold for peripheral artery disease. Securing an impressive $8... |
| 20.05.2024 | R3 Vascular Raises $87M in Series B Financing | R3 Vascular, a Mountain View, CA-based medical device company, raised $87M in Series B funding. The round was led by affiliates of Deerfield Management with participation from existing shareholders including 415 Capital and a strategic inve... |
| 20.05.2024 | R3 Vascular raises $87M for peripheral artery disease stent | figcaption>span]:font-sans"> R3 Vascular raised an $87 million Series B for its bioresorbable scaffold for peripheral artery disease. Why it matters: While still in trial phase, R3 emerges as a potential competitor to Abbott, the... |
| 17.05.2024 | R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee | On the heels of a groundbreaking FDA approval for a major medtech, a Silicon Valley startup is shaping up to be a possible competitor. R3 Vascular recently raised $87 million in venture capital cash to support work on its bioresorbable, dru... |
| 09.05.2024 | R3 Vascular Announces $87 Million in Series B Financing and Appoints Christopher M. Owens as new President and CEO | - |
| 17.10.2023 | Evident Vascular Launches With $35M Series A | SAN JOSE, CA, Evident Vascular announced today that it has launched with a $35 million Series A financing from Vensana Capital. >> Click here for more funding data on Evident Vascular >> To export Evident Vascular funding da... |
| 25.10.2022 | Intressa Vascular secures EUR 18 million in financing to support the development of its multilayer Allay™ Aortic Stent | Intressa Vascular Logo GEMBLOUX, BELGIUM, October 25, 2022 /EINPresswire.com/ -- Intressa Vascular is using its proprietary stent braiding technology to develop an innovative multilayer stent for the treatment of aortic dissection, a life-t... |
| 16.12.2021 | SkyDance Vascular Secures $3.3 Million in Additional Seed Funding | IV therapy is fundamental to patient care, and improvements in IV access make a significant clinical and financial impact. DELRAY BEACH, Fla. (PRWEB) December 16, 2021 SkyDance Vascular (“SkyDance” or “the Company”), a newly formed medical ... |
| 09.10.2020 | StartUPDATES: New developments for healthcare startups | ChromaCode’s HDPCR™ SARS-CoV-2 assay has moved on to the Semi-Finals Round of the XPRIZE Rapid Covid Testing Competition, aiming to increase Covid-19 testing capabilities 100-times past our current standard. R3 Vascular, a medical device co... |
| 22.03.2017 | Singapore: QT Vascular secures $7m from GEM Global, has option to raise more | Premium Medical technology company QT Vascular Ltd. on Tuesday announced that New York-based private alternative investment group GEM Global has agreed to provide it S$10 million ($7 million) in funding over the next 30 months. Continue rea... |
Show more